ConductScience.org, home

Paper33036656

High-throughput approaches for precision medicine in high-grade serous ovarian cancer.

Govindarajan M and 4 others. J Hematol Oncol, 2020. Cited by 63 papers, by iCite.

Cite this record

ConductScience Library. High-throughput approaches for precision medicine in high-grade serous ovarian cancer. Papers, record 33036656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33036656

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
High-throughput approaches for precision medicine in high-grade serous ovarian cancer.
PubMed
Journal
J Hematol Oncol
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
63
iCite
Relative citation ratio, by iCite
2.6
iCite
Revised in PubMed
2023-11-12
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Govindarajan MMeinusha
2Wohlmuth CChristoph
3Waas MMatthew
4Bernardini MQMarcus Q
5Kislinger TThomashttps://orcid.org/0000-0003-3525-5540

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cystadenocarcinoma, SerousMajor topic
Ovarian NeoplasmsMajor topic
Animals
Antineoplastic Agents
Biomarkers, Tumor
Disease Management
Drug Discovery
Female
Gene Expression Profiling
Humans
Liquid Biopsy
Molecular Targeted Therapy
Precision Medicine

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CIHRCanadaPubMed

Source PubMed

Download CSV of grants

References197

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122006311Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/22006311PubMed
215313933Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer.Cancer Res2004https://conductscience.org/library/papers/15313933PubMed
315111296Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.Am J Pathol2004https://conductscience.org/library/papers/15111296PubMed
429359686Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins.Elife2018https://conductscience.org/library/papers/29359686PubMed
522331912High-grade serous ovarian cancer arises from fallopian tube in a mouse model.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22331912PubMed
626002111Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.Lancet2015https://conductscience.org/library/papers/26002111PubMed
722711857BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.J Clin Oncol2012https://conductscience.org/library/papers/22711857PubMed
822875782Does HE4 have a role as biomarker in the recurrence of ovarian cancer?Tumour Biol2012https://conductscience.org/library/papers/22875782PubMed
918827127Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors.Obstet Gynecol2008https://conductscience.org/library/papers/18827127PubMed
1012488461The human plasma proteome: history, character, and diagnostic prospects.Mol Cell Proteomics2002https://conductscience.org/library/papers/12488461PubMed
1122912394The promise of patient-derived xenografts: the best laid plans of mice and men.Clin Cancer Res2012https://conductscience.org/library/papers/22912394PubMed
1221555961Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay.Obstet Gynecol2011https://conductscience.org/library/papers/21555961PubMed
1311600607Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels.J Clin Oncol2001https://conductscience.org/library/papers/11600607PubMed
1425304260Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations.Cancer Res2014https://conductscience.org/library/papers/25304260PubMed
1524637997Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial.J Clin Oncol2014https://conductscience.org/library/papers/24637997PubMed
1630092594Analysis of Circulating Tumor Cells in Ovarian Cancer and Their Clinical Value as a Biomarker.Cell Physiol Biochem2018https://conductscience.org/library/papers/30092594PubMed
1728916367Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet2017https://conductscience.org/library/papers/28916367PubMed
1830981729N-Glycoproteomics of Patient-Derived Xenografts: A Strategy to Discover Tumor-Associated Proteins in High-Grade Serous Ovarian Cancer.Cell Syst2019https://conductscience.org/library/papers/30981729PubMed
1921746896Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21746896PubMed
2017406594Solid-phase extraction of N-linked glycopeptides.Nat Protoc2007https://conductscience.org/library/papers/17406594PubMed

See all 197 referencesDownload CSV of references

Cited by52

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.

PMIDTitleJournalYearIn PapersSource
42908017Early and accurate detection of ovarian cancer by profiling cell-free mitochondrial DNA fragmentomics in multi-ethnic population.Genome Med2026https://conductscience.org/library/papers/42908017PubMed
42568819Biomarkers for predicting and monitoring the efficacy of cancer vaccines.Front Oncol2026https://conductscience.org/library/papers/42568819PubMed
42479110Natural products targeting cytokine-regulated SASP inflammation networks in Ovarian cancer: Implications on immune escape and molecular resistance.Inflammopharmacology2026https://conductscience.org/library/papers/42479110PubMed
42069755Hypermethylation of ZNF154 promotes malignant potential of ovarian cancer cells by diminishing ZNF154/KAP1-mediated ROMO1 repression.Cell Death Dis2026https://conductscience.org/library/papers/42069755PubMed
41634058Mechanisms of FOXK1-regulated glycolipid metabolism in mediating TOX-induced histone lactylation to promote CD8⁺ T cell exhaustion in high-grade serous ovarian cancer.Sci Rep2026https://conductscience.org/library/papers/41634058PubMed
41460259Distinct origins of high-grade serous ovarian carcinoma: genetic and epigenetic evidence linking ovarian and fallopian tube epithelium to clinical outcomes and early detection.Mol Biol Rep2025https://conductscience.org/library/papers/41460259PubMed
41361348Transcriptome analysis of orbital tissue in thyroid eye disease uncovers key pathogenic mediators.Sci Rep2025https://conductscience.org/library/papers/41361348PubMed
41044210ID8 cells manifest phenotypic plasticity and molecular heterogeneity of high-grade serous ovarian cancer in response to the local tissue niche.Sci Rep2025https://conductscience.org/library/papers/41044210PubMed
40696842A stage IV high-grade serous ovarian cancer patient carrying ERBB2 amplification and ERBB2 overexpression benefits from late-line pyrotinib treatment: A case report.Sci Prog2025https://conductscience.org/library/papers/40696842PubMed
40596104Cross modality learning of cell painting and transcriptomics data improves mechanism of action clustering and bioactivity modelling.Sci Rep2025https://conductscience.org/library/papers/40596104PubMed
40503412Functional heterogeneity and clinical implications of CD4+ T cell subtypes in high-grade serous ovarian carcinoma.World J Clin Oncol2025https://conductscience.org/library/papers/40503412PubMed
40416874Uncovering key regulatory pathways and prognostic biomarkers in the tumor microenvironment of high-grade serous ovarian cancer through single-cell RNA sequencing and experimental validation.Front Oncol2025https://conductscience.org/library/papers/40416874PubMed
40356909Epigenetic regulation in oogenesis and fetal development: insights into m6A modifications.Front Immunol2025https://conductscience.org/library/papers/40356909PubMed
40072054Establishment and Its Utility of a Patient-Derived Cell Xenografts (PDCX) Model with Cryopreserved Cancer Cells from Human Tumor.Cells2025https://conductscience.org/library/papers/40072054PubMed
39904996Epigenetic regulation in female reproduction: the impact of m6A on maternal-fetal health.Cell Death Discov2025https://conductscience.org/library/papers/39904996PubMed
39791510Early prediction and risk stratification of ovarian cancer based on clinical data using machine learning approaches.J Gynecol Oncol2025https://conductscience.org/library/papers/39791510PubMed
39669976Inhibition of Selenoprotein I promotes ferroptosis and reverses resistance to platinum chemotherapy by impairing Akt phosphorylation in ovarian cancer.MedComm (2020)2024https://conductscience.org/library/papers/39669976PubMed
39605897Transcriptomic era of cancers in females: new epigenetic perspectives and therapeutic prospects.Front Oncol2024https://conductscience.org/library/papers/39605897PubMed
39546194The Evolution of Next-Generation Sequencing Technologies.Methods Mol Biol2025https://conductscience.org/library/papers/39546194PubMed
39272653The Impact of Liquid Biopsy in Advanced Ovarian Cancer Care.Diagnostics (Basel)2024https://conductscience.org/library/papers/39272653PubMed

See all 52 cited byDownload CSV of cited by

Genes28

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
APOA1335PubTator's text mininghttps://conductscience.org/library/genes/335NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
CD151977PubTator's text mininghttps://conductscience.org/library/genes/977NCBI Gene
CDC42BPA8476PubTator's text mininghttps://conductscience.org/library/genes/8476NCBI Gene
CDCP164866PubTator's text mininghttps://conductscience.org/library/genes/64866NCBI Gene
CT45A1541466PubTator's text mininghttps://conductscience.org/library/genes/541466NCBI Gene
EPCAM4072PubTator's text mininghttps://conductscience.org/library/genes/4072NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
FOLR12348PubTator's text mininghttps://conductscience.org/library/genes/2348NCBI Gene
FOXM12305PubTator's text mininghttps://conductscience.org/library/genes/2305NCBI Gene
HLA-G3135PubTator's text mininghttps://conductscience.org/library/genes/3135NCBI Gene
KDR3791PubTator's text mininghttps://conductscience.org/library/genes/3791NCBI Gene
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
MUC1694025PubTator's text mininghttps://conductscience.org/library/genes/94025NCBI Gene
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene
MYCN4613PubTator's text mininghttps://conductscience.org/library/genes/4613NCBI Gene
PARP1142PubTator's text mininghttps://conductscience.org/library/genes/142NCBI Gene

See all 28 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33036656

GET https://conductscience.org/api/papers/v1/33036656/references?page=2